Paradigm's MD, Paul Rennie, recently participated in the TechKnow Webinar Series, to provide an overview of the enormous addressable market for knee OA and the unmet need that remains for those suffering. Paul discussed the current Phase 3 clinical trial and upcoming events for investors.